Stephan Paul, MD, JD
Paul, Stephan
Professor, Section of Pediatric Hematology/Oncology
J. W. Ruby Memorial Hospital
IMPORTANT: UPDATED Guidance for Patients on COVID-19 including Vaccine Information»
This phase I/II trial identifies the best dose of seclidemstat when given together with
Dr. Niyongere joined the School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center as an Assistant Professor in 2018. Her clinical focus is in acute leukemias,
James R. Cook, M.D., Ph.D., is a Professor of Pathology at the Cleveland Clinic Lerner College of Medicine. He serves as Section Head of Hematopathology in the Department of Laboratory Medicine. Dr. Cook's clinical interests focus on diagnostic hematopathology and molecular diagnostics.
This phase I/II trial studies the side effects and best dose of venetoclax in combination with cedazuridine and
Join together virtually with fellow patients, families, caregivers, and friends to raise awareness for
Dr. Aditi Shastri, M.B.B.S.
David Jacobsohn, MD, ScM is the Division Chief, Blood and Marrow Transplanation at Children's National Hospital in Washington, D.C. Previously, he was at Children’s Memorial Hospital in Chicago, where he served as a member of the Stem Cell Transplant Program staff and as the Director of the Chronic Graft-versus-Host Disease Clinic. He has lectured widely on GvHD/BMT in Europe, Latin America, and the United States. Dr.
Ryotaro Nakamura, MD is Professor, Department of Hematology & Hematopoietic Cell Transplantation; Director, Center for Stem Cell Transplantation at City of Hope.